Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults-Reference-Cited by-同舟云学术

Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults

Published:2012-02-15 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Derry Christopher J¹,Derry Sheena²,Moore R Andrew³

Affiliation:

1. University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Pain Research Unit Churchill Hospital Oxford Oxfordshire UK OX3 7LE

2. Oxford Oxfordshire UK

3. Plymouth UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference91 articles.

1. Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study;Akpunonu;Annals of Emergency Medicine,1995

2. Subcutaneous sumatriptan during the migraine aura;Bates;Neurology,1994

3. Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: a placebo-controlled trial;Bousser;Journal of Internal Medicine,1993

4. Treatment of acute migraine with subcutaneous sumatriptan;Cady;JAMA,1991

5. Repeat-dose efficacy and laboratory safety trial of subcutaneous GR43175C in migraine patients http://www.gsk-clinicalstudyregister.com/

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of intranasal agents for the acute treatment of migraine: a systematic review and network meta-analysis;The Journal of Headache and Pain;2023-09-18

2. Selbstmedikation mit Triptanen bei Migräne;Schmerzmedizin;2023-03

3. Place of next generation acute migraine specific treatments among triptans, non-responders and contraindications to triptans and possible combination therapies;Cephalalgia;2023-02

4. Predicting Sumatriptan Responsiveness Based on Structural Connectivity in Patients Newly Diagnosed With Migraine;Journal of Clinical Neurology;2023

5. Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2022-12-01